Orphan designation: 4-[3-(Methylsulfonyl)phenyl]-1-propylpiperidine x HC1 (pridopidine hydrochloride) Treatment of Huntington’s disease, 20/06/2005 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 11 May 2026 - 8:51

Orphan designation: 4-[3-(Methylsulfonyl)phenyl]-1-propylpiperidine x HC1 (pridopidine hydrochloride) Treatment of Huntington’s disease, 20/06/2005 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-05-288

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters